Project Details
Description
A multicenter, open-label, flexible-dose, parallel-group evaluation of the cataractogenic potential of quetiapine fumarate (Seroquel) and risperidone (Risperdal)
Status | Finished |
---|---|
Effective start/end date | 12/1/03 → 12/31/08 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.